Federal Register Notice - 60 Day

31489

Federal Register / Vol. 73, No. 106 / Monday, June 2, 2008 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondents
Facility personnel ............................................................

Dated: May 19, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E8–12191 Filed 5–30–08; 8:45 am]

Semi-Quantitative Assessment Sheet.

3

or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Active Bacterial Core Surveillance
(ABCs) Projects—New—National Center
for Immunization and Respiratory
Diseases (NCIRD), Centers for Disease
Control and Prevention (CDC).

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–08–08BA]

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Maryam I. Daneshvar,
CDC Acting Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
[email protected].
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques

Number of
responses
per respondent

Number of
respondents

Forms

Background and Brief Description
CDC is requesting OMB approval for
four data collection instruments that
will assist public health officials in
documenting disease burden and
describing the epidemiology of six
bacterial pathogens: group A and group
B streptococcus, Haemophilus
influenzae, Neisseria meningitidis,
Streptococcus pneumoniae, and
methicillin-resistant Staphylococcus
aureus. Case finding is active and
laboratory-based. A standard case report
is completed on all identified cases
through medical record review. The
standard case report form contains
questions on basic demographics,
underlying medical conditions,
vaccinations and risk factors for
infection. The ABCs project is a core
component of an established CDC-stateacademic institution collaborative data
collection network, the Emerging
Infections Program (EIP) Network which
includes the states of California,
Colorado, Connecticut, Georgia,
Maryland, Minnesota, New Mexico,
New York, Oregon and Tennessee. Data
collection is done differently in each
EIP/ABCs surveillance area; for
example, through the cooperation of onsite hospital personnel (e.g., Infection
Control Practitioners or Medical
Records personnel), through medical
record review or clinician interview by
county health department personnel, or
through medical record review by
surveillance personnel.

Average burden
per response
(in hours)

1

5

The data collections have important
practical utility to the government as
well as the American population as a
whole because accurate surveillance
data allows for the development and
evaluation of public health prevention
measures. ABCs is the gold standard for
the collection of population- and
laboratory-based invasive bacterial
disease data in the U.S. No other
nationwide surveillance systems which
monitor these diseases exist. While
similar information may be collected on
a sample basis or from a particular area
of the country, for most diseases,
sampling would not be sufficient for the
states’ need of conducting prevention or
control programs. ABCs collect data
from EIP sites in a uniform manner.
CDC is requesting approval of four
data collection forms. Estimates are
based on CDC’s prior experience with
conducting similar surveillance
activities. ‘‘Respondents’’ for each of the
forms are health departments who will
submit surveillance case report forms.
‘‘Responses’’ for the case report forms
indicate the number of cases of the six
pathogens listed above that are
identified. Number of ‘‘responses’’ for
all case report forms must be estimated
as we do not know before hand how
many cases will occur.
CDC is utilizing technology to
minimize the burden associated with
completing and submitting forms. CDC
will provide to each EIP site a Microsoft
Access database that mirrors the data
collection forms. Surveillance staff at
each participating EIP site will enter
data from the data collection form into
the database. 100% of the forms
included in this data collection package
will be submitted to CDC electronically.
Password-protected databases are
posted to site-specific folders on a
secure CDC ftp site.
There are no costs to respondents
other than their time.

jlentini on PROD1PC65 with NOTICES

ESTIMATED ANNUALIZED BURDEN HOURS
Form name

Type of respondent

ABCs Case Report Form ...........................

State Health Department.

VerDate Aug<31>2005

19:06 May 30, 2008

Jkt 214001

PO 00000

Frm 00065

Number of
responses
per respondent

Number of
respondents

Fmt 4703

10

Sfmt 4703

Average burden
per response
(in hours)

809

E:\FR\FM\02JNN1.SGM

20/60

02JNN1

Total burden
(in hours)
2697

31490

Federal Register / Vol. 73, No. 106 / Monday, June 2, 2008 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Average burden
per response
(in hours)

Total burden
(in hours)

Type of respondent

Invasive
Methicillin-resistant
Staphylococcus aureus ABCs Case Report
Form.
ABCs Invasive Pneumococcal Disease in
Children Case Report Form.
Neonatal Group B Streptococcal Disease
Prevention Tracking Form.

State Health Department.

10

609

20/60

2030

State Health Department.
State Health Department.

10

41

10/60

68

10

37

20/60

123

............................

............................

............................

4918

Total ....................................................

..................................

Dated: May 23, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E8–12192 Filed 5–30–08; 8:45 am]

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

BILLING CODE 4163–18–P

Advisory Committee on Immunization
Practices (ACIP)

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:

Centers for Disease Control and
Prevention
Public Health Service Act (PHS);
Delegation of Authority
Notice is hereby given that I have
delegated to the Director, National
Center for Preparedness, Detection and
Control of Infectious Diseases
(NCPDCID), and the Director, Division
of Global Migration and Quarantine
(DGMQ), NCPDCID, with authority to
redelegate, the authorities vested in the
Director, Centers for Disease Control
and Prevention, under sections 361(a),
(b), (c), (d), and 362, Title III, of the PHS
Act (Control of Communicable Diseases,
42 U.S.C. 264 and 265. The authority
delegated under 361(a) does not include
the authority to promulgate regulations.
This delegation became effective upon
date of signature. In addition, I have
affirmed and ratified any actions taken
by the Director, NCPDCID, the Director,
DGMQ, NCPDCID, or their subordinates
which involved the exercise of
authorities delegated herein prior to the
effective date of the delegation.

jlentini on PROD1PC65 with NOTICES

Number of
responses
per respondent

Number of
respondents

Form name

Dated: May 20, 2008.
Julie Louise Gerberding,
Director, Centers for Disease Control and
Prevention.
[FR Doc. E8–12176 Filed 5–30–08; 8:45 am]
BILLING CODE 4160–18–M

VerDate Aug<31>2005

19:06 May 30, 2008

Jkt 214001

Centers for Disease Control and
Prevention

Times and Dates: 8 a.m.–6 p.m., June 25,
2008. 8 a.m.–5 p.m., June 26, 2008.
Place: CDC, Tom Harkin Global
Communications Center, 1600 Clifton Road,
NE., Building 19, Kent ‘‘Oz’’ Nelson
Auditorium, Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available.
Purpose: The committee is charged with
advising the Director, CDC, on the
appropriate uses of immunizing agents. In
addition, under 42 U.S.C. 1396s, the
committee is mandated to establish and
periodically review and, as appropriate,
revise the list of vaccines for administration
to vaccine-eligible children through the
Vaccines for Children (VFC) program, along
with schedules regarding the appropriate
periodicity, dosage, and contraindications
applicable to the vaccines.
Matters to be Discussed: The agenda will
include discussions on Rotavirus Vaccines;
Combination Vaccines; MMRV Vaccine;
Human Papillomavirus Vaccines;
Pneumococcal Vaccines; Measles Outbreaks
in the United States (2008); Adult
Immunization Schedule; Anthrax Vaccine;
Influenza Vaccines; Rabies Vaccine and
Biologicals; Vaccine Supply; and
Immunization Safety Update. There may be
VFC voting on the Rotavirus, Combination
and Human Papillomavirus Vaccines.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Antonette Hill, Immunization Services
Division, National Center for Immunization
and Respiratory Diseases, CDC, 1600 Clifton
Road, NE., (E–05), Atlanta, Georgia 30333,
Telephone (404) 639–8836, Fax (404) 639–
8905.
The Director, Management Analysis and
Services Office, has been delegated the

PO 00000

Frm 00066

Fmt 4703

Sfmt 4703

authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the CDC and ATSDR.
Dated: May 27, 2008.
Elaine Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–12234 Filed 5–30–08; 8:45 am]
BILLING CODE 4160–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Food Safety Research; Investigations
Focused on Promoting the Safety of
Produce
AGENCY:

Food and Drug Administration,

HHS.
ACTION:

Notice.

SUMMARY: The Food and Drug
Administration (FDA-Center for Food
Safety and Applied Nutrition (CFSAN))
is announcing the availability of
approximately $1.0 million in research
funds for fiscal year (FY) 2008. It is
anticipated that individual grants will
receive a total of $250,000 to $500,000
to cover both direct and indirect costs.
These funds will be used to support
research efforts to advance the safe
transportation and preparation of
produce and to help reduce the
incidence of foodborne illness that may
be associated with fresh produce
consumption. The award will provide
18 months of support. There will be no
additional years of noncompetitive
continuation support. A copy of the full
text of this announcement will be
posted in Grants.gov and on FDA’s
Center for Food Safety and Applied
Nutrition Web site at http://
www.cfsan.fda.gov/list.html.
Key Dates: Receipt Date: Applications
are due within 90 days after the
publication of the funding opportunity
in the Federal Register.

E:\FR\FM\02JNN1.SGM

02JNN1